Hereditary Spastic Paraplegia clinical trials at University of California Health
2 in progress, 1 open to eligible people
open to all eligible people
This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
Sorry, accepting new patients by invitation only
The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.
Our lead scientists for Hereditary Spastic Paraplegia research studies include Joseph Gleeson.